Sattva Sukun Lifecare Limited (SSLL), formerly known as Mayukh Dealtrade Limited, has reported a robust performance for the second quarter of fiscal year 2026, along with the successful completion of a significant rights issue.

Q2 FY2026 Financial Highlights

SSLL reported standalone net sales of Rs 195.98 lakhs for Q2 FY2026, demonstrating the company's continued growth trajectory. The company's profit for the quarter stood at Rs 60.40 lakhs, indicating a solid bottom-line performance.

Rights Issue and Capital Allocation

SSLL completed a rights issue of 19.16 crore equity shares, raising a total of Rs 1,916 lakhs. This capital infusion is expected to provide the company with resources to pursue its expansion plans and strategic investments.

The company has allocated the funds raised from the rights issue as follows:

Strategic Investment and Expansion

A significant portion of the rights issue proceeds, Rs 1,000 lakhs, has been earmarked for strategic investment in SSLL's subsidiary, PavaPuri Export Private Limited. This move suggests that the company is focusing on strengthening its group structure and potentially expanding its export-oriented business.

Additionally, SSLL has allocated Rs 287.82 lakhs towards business expansion plans. While specific details of these plans were not provided, this investment indicates the company's commitment to growth and market expansion.

Financial Position

Based on the latest available financial data as of March 2025:

The company's balance sheet shows growth in total assets and current assets, indicating improved liquidity and operational capacity. The increase in revenue and net profit for FY 2025 demonstrates SSLL's strong financial performance.

Conclusion

Sattva Sukun Lifecare Limited's Q2 FY2026 results, coupled with the completion of its rights issue, indicate a company on a growth trajectory. The strategic allocation of funds towards subsidiary investment and business expansion suggests that SSLL is positioning itself for future opportunities in the market.

Investors and stakeholders may be interested in observing how these investments translate into long-term value creation for the company. As always, it's important for investors to conduct their own research and consider their individual financial goals before making investment decisions.

Sattva Sukun Lifecare Limited , a Mumbai-based company, held a significant Extraordinary General Meeting (EGM) on July 19, 2025, via video conferencing. The meeting saw overwhelming support from shareholders, with three crucial resolutions receiving near-unanimous approval.

Key Resolutions Passed

1. Director Appointments:

   • Mr. Tanmay Paresh Shah was regularized as a Non-Executive Independent Director.
   • Mr. Gaurav Surendra Nair was regularized as a Non-Executive Non-Independent Director.

2. Strategic Acquisition: Shareholders approved the acquisition of 51% and above equity shares of Pavapuri Export Private Limited.

Meeting Highlights

• Attendance: 45 members participated in the EGM out of a total of 32,581 shareholders on the record date.
• Voting Process: The e-voting period was conducted from July 16-18, 2025.
• Scrutiny: Brajesh Gupta & Co. was appointed as the scrutinizer for the voting process.

Detailed Voting Results

The voting results, as reported by the scrutinizer, show overwhelming support for all three resolutions:

Shareholder Participation

• Total Votes Cast: 87,567,632 votes were polled, representing 22.83% of the total shareholding.
• Promoter Participation: 24,493,777 shares (99.80% of promoter holding) voted in favor of all resolutions.
• Public Participation: 63,073,855 shares from the public category participated in the voting.

The strong shareholder support for these resolutions indicates confidence in the company's strategic decisions and leadership appointments. The acquisition of Pavapuri Export Private Limited suggests that Sattva Sukun Lifecare is pursuing growth opportunities that align with its business objectives.

This EGM marks a significant milestone for Sattva Sukun Lifecare Limited, potentially setting the stage for future growth and expansion. The company's transparent approach to corporate governance, as evidenced by the detailed voting results and scrutinizer's report, is likely to be viewed positively by investors and stakeholders.